1) Graus F, Delattre JY, Antoine JC, et al:Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004;75:1135-40 2) 河内泉:傍腫瘍性神経症候群と自己抗体.BRAIN and NERVE 2018;70:329-39 3) Solimena M, Folli F, Aparisi R, et al:Autoantibodies to GABA-ergic neurons and paraneoplastic beta cells in stiff-man syndrome. N Engl J Med 1990;322:1555-60 4) Graus F, Saiz A, Dalmau J:Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-17 5) 林祐一,犬塚貴:傍腫瘍性神経症候群.BRAIN and NERVE 2013;65:385-93 6) Dalmau J, Lancaster E, Matinez-Hermandez E, et al:Clinical experience and laboratory investigations in patients with antiNMDAR encephalitis. Lancet Neurol 2011;10:63-74 7) Antoine JC, Camdessanché JP:Treatment options in paraneoplastic disorders of the peripheral nervous system. Curr Treat Options Neurol 2013;15:210-23 8) Blyakhman I, Chakravarthy K:Update review and treatment recommendations on paraneoplastic neurologic syndromes and chronic pain. Pain Physician 2013;22:433-55 9) Grativvol RS, Cavalcante WCP, Castro LHM, et al:Updates in diagnosis and treatment of paraneoplastic neurologic syndromes. Curr Oncol Rep 2018;20(11):92 10) Dalmau J, Gleichmann AJ, Hughes EG, et al:Anti-NMDA-receptor encephalitis:case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-8 11) Vincent A, Buckley C, Schott JM, et al:Potassium channel antibody-associated encephalopathy:a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12 12) Lai M, Hughes EG, Peng X, et al:AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-34 13) Vedeler CA, Antoine JC, Giometto B, et al:Management of Paraneoplastic neurological syndromes:report of an EFNS task force. Eur J Neurology 2006;13:682-90